OverviewSuggest Edit

Natus Medical is a leading manufacturer of medical devices and software and a service provider for the Newborn Care, Neurology, Sleep, Hearing and Balance markets. Natus products are used in hospitals, clinics and laboratories worldwide. The Company's mission is to improve outcomes and patient care in target markets through innovative screening, diagnostic and treatment solutions.
TypePublic
Founded1989
HQPleasanton, US
Websitenatus.com
Employee Ratings3.2

Latest Updates

Employees (est.) (Dec 2017)1,160
Job Openings83
Revenue (FY, 2018)$530.9 M(+6%)
Share Price (Mar 2019)$27 (-1%)

Key People/Management at Natus Medical

Jonathan A. Kennedy

Jonathan A. Kennedy

President, Chief Executive Officer and Director
Drew Davies

Drew Davies

Executive Vice President and Chief Financial Officer.
Austin F. Noll

Austin F. Noll

Vice President and General Manager, Neurology
D. Christopher Chung

D. Christopher Chung

Vice President Medical Affairs, Quality and Regulatory
Carsten Buhl

Carsten Buhl

President & CEO, Otometrics SBU
Leslie McDonnell

Leslie McDonnell

Vice President and General Manager, Newborn Care
Show more

Natus Medical Office Locations

Natus Medical has offices in Pleasanton, Mundelein, Seattle, Hauppauge and in 9 other locations
Pleasanton, US (HQ)
6701 Koll Center Pkwy #120
Golden, US
720 Corporate Cir Suite A
Hauppauge, US
150 Motor Pkwy #106
Middleton, US
3150 N Pleasant View Rd
Mundelein, US
Bio Logic Plaza
San Carlos, US
1501 Industrial Rd
Show all (13)
Report incorrect company information

Natus Medical Financials and Metrics

Natus Medical Revenue

Natus Medical's revenue was reported to be $530.89 m in FY, 2018
USD

Revenue (FY, 2018)

530.9m

Gross profit (FY, 2018)

312.9m

Gross profit margin (FY, 2018), %

58.9%

Net income (FY, 2018)

(22.9m)

EBIT (FY, 2018)

(24.6m)

Market capitalization (18-Mar-2019)

912.7m

Closing stock price (18-Mar-2019)

27.0

Cash (31-Dec-2018)

56.4m

EV

960.8m
Natus Medical's current market capitalization is $912.7 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

344.1m355.8m375.9m381.9m501.0m530.9m

Revenue growth, %

3%6%2%

Cost of goods sold

142.1m145.5m144.6m213.4m218.0m

Gross profit

202.0m230.4m237.3m287.6m312.9m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

85.4m85.6m86.3m89.9m89.4m91.9m94.6m87.3m96.0m90.9m124.7m122.2m122.6m128.6m130.7m130.6m

Cost of goods sold

34.1m35.7m35.3m34.3m35.1m33.8m35.5m32.5m37.9m32.2m56.9m54.6m47.1m55.4m52.9m51.6m

Gross profit

51.3m49.9m51.0m55.5m54.3m58.1m59.1m54.9m58.1m58.7m67.7m67.6m75.5m73.2m77.8m79.1m

Gross profit Margin, %

60%58%59%62%61%63%62%63%61%65%54%55%62%57%60%61%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

56.1m66.6m82.5m213.6m89.0m56.4m

Accounts Receivable

Inventories

37.7m40.1m48.6m49.6m71.5m79.7m

Current Assets

196.8m217.8m241.4m405.8m305.6m285.8m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

44.2m59.6m56.0m57.8m67.0m73.2m82.2m81.3m96.3m81.1m103.8m80.3m

Inventories

39.4m35.5m35.5m37.1m41.4m44.9m46.1m45.7m43.6m51.7m67.7m69.3m

Current Assets

182.6m198.3m189.9m193.3m218.2m228.4m247.5m228.3m245.9m266.0m316.5m287.0m

PP&E

24.4m21.5m21.1m19.3m18.2m18.4m18.0m17.6m17.2m18.1m20.9m20.9m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

22.9m32.5m37.9m42.6m(20.3m)(22.9m)

Depreciation and Amortization

12.8m11.8m16.0m16.9m30.1m33.9m

Inventories

(2.3m)(2.0m)(12.2m)(7.7m)7.6m(7.4m)

Accounts Payable

(1.4m)(7.6m)3.3m(5.0m)(1.4m)4.1m
Quarterly
USDY, 2018

EV/EBIT

-39.1 x

EV/CFO

29.1 x

Financial Leverage

1.6 x
Show all financial metrics
Report incorrect company information

Natus Medical Online and Social Media Presence

Embed Graph
Report incorrect company information

Natus Medical News and Updates

NATUS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Natus Medical Incorporated To Contact The Firm

NEW YORK, Feb. 27, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Natus Medical Incorporated ("Natus" or the "Company") (NASDAQ: BABY). If you invested in Natus stock or options and would like to discuss your...

Global Hearing Healthcare Devices Market 2019-2025 Enhancement with Latest Technology & Growth by Key Players: William Demant, Sonova, GN Store Nord, Sivantos Group, Widex, Starkey, Cochlear, MED-EL GmbH, Natus Medical

Summary:“Hearing Healthcare Devices” are designed to improve hearing by making sound audible to a person with hearing loss. These devices also known as Hearing aids which are classified as medical devices in most countries, and regulated by the respective regulations. Posted via Industry Today. Foll…

Natus Medical Announces Fourth Quarter and Full Year 2018 Financial Results

PLEASANTON, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY) (the “Company” or “Natus”) today announced financial results for the three months and full year ended December 31, 2018.

Natus Medical Announces Continued Board Refreshment with Two New Independent Directors

PLEASANTON, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY) announced today a significant refreshment of its board of directors with the appointment of Alice D. Schroeder, former CEO and Chair of WebTuner Corporation and Thomas J. Sullivan, President and CEO of …

Multi parameter Patient Monitoring Equipment Market with key players: Nihon Kohden Corporation, Spacelabs Healthcare, Medtronic, and Natus Medical.

The Global Multi parameter Patient Monitoring Equipment Market Report includes a comprehensive analysis of the present market. The report starts with the basic Global Multi parameter Patient Monitoring Equipment Market overview and then goes into each and every detail. Posted via Industry Today. Fol…

The Worldwide Market for Intracranial Pressure Monitoring Devices (2019-2023): Leading Players are Integra LifeSciences, Medtronic, Natus Medical and RAUMEDIC

DUBLIN, Dec 19, 2018 /PRNewswire/ -- The "Global Intracranial Pressure Monitoring Devices Market 2019-2023" report has been added to ResearchAndMarkets.com's offering. The global intracranial pressure monitoring devices market is forecasted to grow at a CAGR of nearly 7% during the...
Show more
Report incorrect company information

Natus Medical Frequently Asked Questions

  • When was Natus Medical founded?

    Natus Medical was founded in 1989.

  • Who are Natus Medical key executives?

    Natus Medical's key executives are Jonathan A. Kennedy, Drew Davies and Austin F. Noll.

  • How many employees does Natus Medical have?

    Natus Medical has 1,160 employees.

  • What is Natus Medical revenue?

    Latest Natus Medical annual revenue is $530.9 m.

  • What is Natus Medical revenue per employee?

    Latest Natus Medical revenue per employee is $457.7 k.

  • Who are Natus Medical competitors?

    Competitors of Natus Medical include Mauna Kea Technologies, Sight Sciences and Biovotion.

  • Where is Natus Medical headquarters?

    Natus Medical headquarters is located at 6701 Koll Center Pkwy #120, Pleasanton.

  • Where are Natus Medical offices?

    Natus Medical has offices in Pleasanton, Mundelein, Seattle, Hauppauge and in 9 other locations.

  • How many offices does Natus Medical have?

    Natus Medical has 13 offices.